| Malignant Germ Cell Tumor studied in …STUDIED_INderived114 of 114show fewer |
|---|
| → studied in | NCT07705035Phase 1 · recruiting DBC-664 in Adult Patients With Solid Tumors · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Malignant Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01445288completed Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Germinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04684368Phase 2 · recruiting A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Embryonal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03210714Phase 2 · active not recruiting Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 114 trials mapped (55 active) | — | — | Childhood Malignant Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03698994Phase 2 · active not recruiting Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 114 trials mapped (55 active) | — | — | Malignant Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03158064Phase 2 · active not recruiting Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Seminoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05529251Phase 2 · recruiting De-escalation Study for Stage IIa/IIb < 3 cm Seminoma · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Seminoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07809178not yet recruiting China Treatment Trial for Tumor in Sellar Region With Unruptured Intracranial Aneurysm · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Germinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05857969Phase 1 · recruiting Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling · condition mapped CURATED_BROADER · 114 trials mapped (55 active) | — | — | Malignant Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03067181Phase 3 · recruiting Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Malignant Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06368817Phase 2 · recruiting A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Basal Ganglia Germinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06060873recruiting MAGESTIC Trial: MiRNA in Detecting Active Germ Cell Tumors in Early Suspected and MetastaTIC Disease Trial · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Malignant Testicular Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04715191Phase 1 · recruiting Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Yolk Sac Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04320888Phase 2 · active not recruiting Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial · condition mapped CURATED_BROADER · 114 trials mapped (55 active) | — | — | Malignant Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03155620Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) · condition mapped CURATED_BROADER · 114 trials mapped (55 active) | — | — | Malignant Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02721732Phase 2 · active not recruiting Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic · condition mapped CURATED_BROADER · 114 trials mapped (55 active) | — | — | Malignant Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04284774Phase 2 · active not recruiting Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial · condition mapped CURATED_BROADER · 114 trials mapped (55 active) | — | — | Malignant Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213652Phase 2 · active not recruiting Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 114 trials mapped (55 active) | — | — | Malignant Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04195555Phase 2 · active not recruiting Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 114 trials mapped (55 active) | — | — | Malignant Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07662200early Phase 1 · not yet recruiting A Simplified Regimen to Prevent Nausea and Vomiting Using Netupitant/Palonosetron in Germ Cell Cancer Patients Receiving Chemotherapy · condition mapped ALIAS · 114 trials mapped (55 active) | — | — | Malignant Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Seminoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213704Phase 2 · active not recruiting Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 114 trials mapped (55 active) | — | — | Malignant Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02375204Phase 3 · active not recruiting Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors · condition mapped ALIAS · 114 trials mapped (55 active) | — | — | Malignant Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02537548NA · active not recruiting Retroperitoneal Lymph Node Dissection in Treating Patients With Testicular Seminoma · condition mapped CURATED_BROADER · 114 trials mapped (55 active) | — | — | Testicular Seminoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06191575suspended 7 Tesla MRI Neuroimaging in Testicular Cancer Patients With Hypogonadism and on Androgen Replacement Therapy · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Malignant Testicular Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07601672NA · not yet recruiting PRISTINE Trial: PRoton Beam Therapy In Seminoma - Toxicity INvestigation and Evaluation of Outcome · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Seminoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04897321Phase 1 · recruiting B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) · condition mapped ALIAS · 114 trials mapped (55 active) | — | — | Malignant Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04901702Phase 1/Phase 2 · recruiting Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma · condition mapped CURATED_BROADER · 114 trials mapped (55 active) | — | — | Malignant Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07589361not yet recruiting Safety and Efficacy of Vertebral Body-Sparing Craniospinal Irradiation With Proton Therapy in Pediatric Tumors · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Germinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213678Phase 2 · completed Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 114 trials mapped (55 active) | — | — | Malignant Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05969860Phase 2 · recruiting At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer · condition mapped CURATED_BROADER · 114 trials mapped (55 active) | — | — | Malignant Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07218913Phase 1 · recruiting Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors · condition mapped CURATED_BROADER · 114 trials mapped (55 active) | — | — | Malignant Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06638931Phase 2 · recruiting Agnostic Therapy in Rare Solid Tumors · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Yolk Sac Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213665Phase 2 · completed Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 114 trials mapped (55 active) | — | — | Malignant Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02433197NA · completed Effectiveness of an Individualized Program of Muscular Strength and Endurance Program for Improving Germ Cell Cancer · condition mapped ALIAS · 114 trials mapped (55 active) | — | — | Malignant Testicular Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03526250Phase 2 · completed Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 114 trials mapped (55 active) | — | — | Malignant Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07498959NA · recruiting Primary RPLND Versus Systemic Chemotherapy in Good-prognosis Metastatic Testicular Cancer · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Seminoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05500391Phase 2 · recruiting Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring · condition mapped CURATED_BROADER · 114 trials mapped (55 active) | — | — | Testicular Seminoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04435756active not recruiting A Study of miRNA 371 in Patients With Germ Cell Tumors · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Seminoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07463508NA · recruiting Evaluation of Bile Acid Concentrations and Their Signaling as Markers of Testicular Tumorigenesis and Germ Cell Tumor Chemosensitivity · condition mapped ALIAS · 114 trials mapped (55 active) | — | — | Malignant Testicular Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05103631Phase 1 · active not recruiting Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Yolk Sac Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06309745recruiting THERApy De-escalation for TESTicular Cancer · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Seminoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07148050Phase 1 · recruiting Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Yolk Sac Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04377932Phase 1 · active not recruiting Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Yolk Sac Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03937843Phase 2 · active not recruiting Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Seminoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04876456Phase 2 · active not recruiting A Phase II Trial of Cabozantinib With Patients With Refractory GCTs · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Seminoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05345158NA · recruiting R-RPLND as First-line Treatment for Clinical Stage IIA/B Testicular Seminoma · condition mapped CURATED_BROADER · 114 trials mapped (55 active) | — | — | Testicular Seminoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02341989Phase 3 · active not recruiting Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Seminoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01602666Phase 2 · completed Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Childhood Germinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01453660active not recruiting Acute Changes in Endothelial Function in Germ Cell Tumor Patients Treated With Cisplatin and Untreated Germ Cell Tumor Controls · condition mapped ALIAS · 114 trials mapped (55 active) | — | — | Malignant Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00996710active not recruiting Genomic Structural Variation in Cancer Susceptibility · condition mapped ALIAS · 114 trials mapped (55 active) | — | — | Malignant Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07224568Phase 1 · not yet recruiting Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Yolk Sac Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06198296Phase 1 · recruiting Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Yolk Sac Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05564026recruiting Molecular Epidemiology of Pediatric Germ Cell Tumors · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Germinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06275854terminated YASU Research Registry: For Young Adults With Cancer · condition mapped ALIAS · 114 trials mapped (55 active) | — | — | Malignant Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06341998Phase 2/Phase 3 · completed Clinical Study of Chemotherapy in the Treatment of Recurrent/Refractory Yolk Sac Tumor in Children · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Yolk Sac Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06470464Phase 2 · completed Thalidomide Combined With Chemotherapy in the Treatment of Relapsed or Refractory Yolk Sac Tumor · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Yolk Sac Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06133543NA · recruiting Robot-assisted ICG-guided Sentinel Node Biopsy in Testicular Cancer · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Seminoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06144736Phase 2 · recruiting PRIMETEST II - Clinical Stage II A/B Seminoma Treated With RA-RPLND · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Seminoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04671693NA · active not recruiting A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors. · condition mapped ALIAS · 114 trials mapped (55 active) | — | — | Testicular Mixed Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03426865completed Role of Axumin PET Scan in Germ Cell Tumor · condition mapped ALIAS · 114 trials mapped (55 active) | — | — | Malignant Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00638898Phase 1 · completed Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Ovarian Mixed Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01593241Phase 2 · terminated Therapy De-escalation in Seminoma Stage IIA/B · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Seminoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05142982NA · recruiting Radiotherapy vs Observation for Post Chemotherapy Residual Mass in Advanced Seminoma · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Seminoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03220035Phase 2 · completed Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial) · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Malignant Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03233204Phase 2 · completed Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 114 trials mapped (55 active) | — | — | Childhood Malignant Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04648462recruiting Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Germinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06329323not yet recruiting SerUm and Plasma MicroRNAs in Malignant Ovarian gERm Cell Tumours · condition mapped ALIAS · 114 trials mapped (55 active) | — | — | Malignant Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02303015completed Toxicity Attributed to Genetic Polymorphisms in Testicular Germ Cell Tumor Survivors · condition mapped ALIAS · 114 trials mapped (55 active) | — | — | Malignant Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04402593NA · withdrawn Music Therapy For The Treatment Of Cisplatin Induced Tinnitus In Patients With rGCC: A Pilot Study · condition mapped CURATED_BROADER · 114 trials mapped (55 active) | — | — | Malignant Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03860376completed Ex Vivo Drug Sensitivity Testing and Mutation Profiling · condition mapped CURATED_BROADER · 114 trials mapped (55 active) | — | — | Malignant Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02429687Phase 3 · recruiting TC or BEP in Treating Patients With Malignant Ovarian Germ Cell Tumors · condition mapped ALIAS · 114 trials mapped (55 active) | — | — | Malignant Ovarian Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04914026recruiting MicroRNA as Markers in Testicular Cancer · condition mapped ALIAS · 114 trials mapped (55 active) | — | — | Malignant Testicular Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00983398Phase 1/Phase 2 · unknown Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell Tumors · condition mapped CURATED_BROADER · 114 trials mapped (55 active) | — | — | Malignant Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00053352Phase 3 · completed Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Childhood Malignant Ovarian Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00536601NA · completed High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors · condition mapped CURATED_BROADER · 114 trials mapped (55 active) | — | — | Malignant Testicular Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01055067Phase 2 · terminated ARQ 197 for Participants With Relapsed or Refractory Germ Cell Tumors · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Seminoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01037790Phase 2 · completed Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer · condition mapped CURATED_BROADER · 114 trials mapped (55 active) | — | — | Extragonadal Seminoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01441154completed Metabolic Effects of Synthetic Thyroid Hormone for Thyroid Cancer Treatment · condition mapped ALIAS · 114 trials mapped (55 active) | — | — | Thyroid Carcinoma Arising in Struma Ovarii | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01154816Phase 2 · completed Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia · condition mapped CURATED_BROADER · 114 trials mapped (55 active) | — | — | Childhood Malignant Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02689219Phase 2 · terminated Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Embryonal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01305200Phase 3 · completed Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant · condition mapped CURATED_BROADER · 114 trials mapped (55 active) | — | — | Malignant Testicular Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01159067Phase 2 · terminated Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload · condition mapped CURATED_BROADER · 114 trials mapped (55 active) | — | — | Malignant Testicular Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02272816Phase 2 · completed Carboplatin AUC-10 With Early PET Scanning in Metastatic Seminoma · condition mapped CURATED_BROADER · 114 trials mapped (55 active) | — | — | Seminoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01434355completed DNA Analysis in Samples From Younger Patients With Germ Cell Tumors and Their Parents or Siblings · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Childhood Malignant Ovarian Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00467051Phase 2 · completed Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors · condition mapped ALIAS · 114 trials mapped (55 active) | — | — | Childhood Malignant Extragonadal Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01484015Phase 1 · completed Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Malignant Testicular Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01080521completed Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Ovarian Dysgerminoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01851200Phase 2 · completed Brentuximab Vedotin (SGN-35) as Salvage Treatment for CD30-positive Germ Cell Tumors · condition mapped ALIAS · 114 trials mapped (55 active) | — | — | Malignant Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03262207unknown Epigenetic Integrity of Spermatozoa in Patients With Germinal Testicular Tumours · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Seminoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00795769Phase 2 · completed Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant · condition mapped CURATED_BROADER · 114 trials mapped (55 active) | — | — | Malignant Testicular Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00957905Phase 2 · completed Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors · condition mapped CURATED_BROADER · 114 trials mapped (55 active) | — | — | Extragonadal Seminoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00408681NA · completed Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant · condition mapped CURATED_BROADER · 114 trials mapped (55 active) | — | — | Malignant Testicular Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00897442completed Collecting Tumor Samples From Patients With Gynecological Tumors · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Childhood Malignant Ovarian Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01887340Phase 2 · unknown Therapeutic Strategy Guided by PET-TDM for Patients With Seminoma · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Seminoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01808534Phase 2 · terminated Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Malignant Extragonadal Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01242631Phase 2 · completed Everolimus for Patients With Relapsed/Refractory Germ Cell Cancer · condition mapped ALIAS · 114 trials mapped (55 active) | — | — | Malignant Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01088763Phase 1 · terminated Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Childhood Central Nervous System Choriocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00705094completed Cardiac Function and Cardiovascular Risk Profile in Testicular Cancer Patients · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Seminoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00387920Phase 1 · completed Sunitinib in Treating Young Patients With Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Childhood Central Nervous System Choriocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00929903Phase 1 · completed Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Childhood Central Nervous System Choriocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00012181Phase 1 · completed Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas · condition mapped CURATED_BROADER · 114 trials mapped (55 active) | — | — | Childhood Malignant Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00994500Phase 1 · completed Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Childhood Central Nervous System Choriocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00077454Phase 1 · completed Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors · condition mapped CURATED_BROADER · 114 trials mapped (55 active) | — | — | Childhood Malignant Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00091182Phase 2 · completed Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Childhood Malignant Ovarian Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101270Phase 1 · completed Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas · condition mapped CURATED_BROADER · 114 trials mapped (55 active) | — | — | Childhood Malignant Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00281944Phase 1 · completed Combination Chemotherapy in Treating Young Patients With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Childhood Central Nervous System Choriocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01076530Phase 1 · completed Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Childhood Central Nervous System Choriocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00060372Phase 1 · completed Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Ovarian Embryonal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004074Phase 1 · completed Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu · condition mapped CURATED_BROADER · 114 trials mapped (55 active) | — | — | Malignant Testicular Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00028496Phase 1 · completed Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer · condition mapped CURATED_BROADER · 114 trials mapped (55 active) | — | — | Malignant Testicular Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00042952Phase 2 · terminated Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Ovarian Dysgerminoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01558778NA · withdrawn Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant · condition mapped CURATED_BROADER · 114 trials mapped (55 active) | — | — | Malignant Testicular Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00204633Phase 2 · completed Darbepoetin Alfa in Patients With "Poor Prognosis" Germ Cell Tumor Treated With High-Dose Chemotherapy (HD-VIP) · condition mapped ONTOLOGY_EXACT · 114 trials mapped (55 active) | — | — | Dysgerminoma | 1 | Observed | clinicaltrials | graph → |